APH Amphenol notches 29 percent Q4 2025 EPS beat dips slightly as investors react tepidly What are the biggest risks facing Elite ETS stock MNY MoneyHero reports far wider than expected Q3 2025 loss even as shares rise slightly Pfizer Inc PFE Strategic CDK Inhibitor Supply Partnership with Relay Therapeutics Validates Atirmociclib Commercial Potential in Metastatic Breast Cancer PGZ Principal files preliminary quarterly earnings report with core performance metrics yet to be disclosed FedEx Corporation FDX Valuation Assessment Following a 12Month 889 Share Price Rally Is Microvast Holdings MVST stock testing resistance Q4 2025 Profit Disappoints US Airline Sector Pricing Dynamics Amid Volatile Fuel Costs and Regulatory Scrutiny